David Light
8Patents
6h-index
13Co-inventors
52Inventor score
Filing activity: Apr 30, 2003 → Jul 16, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8501185B2 | Dimeric molecular complexes | Chemistry; Metallurgy | 23 | Active |
| US7250168B2 | Tissue factor targeted thrombomodulin fusion proteins as anticoagulants | Chemistry; Metallurgy | 16 | Expired |
| US9023351B2 | Anti-mesothelin antibodies and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US7579000B2 | Tissue factor targeted antibodies as anticoagulants | Physics | 10 | Expired |
| US7622122B2 | Methods of using novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants | Chemistry; Metallurgy | 7 | Active |
| US7622457B2 | Polynucleotides encoding anticoagulant fusion proteins | Chemistry; Metallurgy | 6 | Active |
| US9624309B2 | Monospecific and multispecific antibodies and method of use | Emerging Cross-Sectional Technologies | 1 | Active |
| US7960532B2 | Polynucleotides encoding anticoagulant antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.